Pregabalin, the drug is one of the most promising drugs in the development of epilepsy treatment drugs, with better curative effect and more convenient administration. It can also be used to treat pain and anxiety.
Pregabalin also known as lyrica is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.
It is used as an add-on therapy for partial seizures in epilepsy.
It decreases pain but causes more drowsiness and visual abnormalities when administered before surgery.
It is taken orally
Headache, dizziness, tiredness, disorientation, memory loss, poor coordination, dry mouth, vision problems, and weight gain are all common side effects.
Pregabalin is a gabapentoid that works by blocking calcium channels.
In 2004, the FDA approved pregabalin for medicinal use in the United States.
It was created as a replacement for gabapentin.
As of 2019, it is available as a generic drug in several countries, including the United States. In April 2021, a generic version of the extended-release formulation will be available in the United States. With more than 9 million prescriptions written in 2019, it was the 81st most widely prescribed drug in the United States. Pregabalin is classified as a Schedule V controlled substance in the United States under the Controlled Substances Act of 1970.
In the United Kingdom, it is classified as a Class C controlled substance.
1kg, 5kg, 10kg, 25kg